Grantham, Mayo, Van Otterloo & Co (GMO)’s Ares Capital ARCC Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ARCC Stock Details ARCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-71,310	Closed	-$1.4M	–	673
2021 Q2	$1.4M	Hold	71,310	–	–	0.01%	507
2021 Q1	$1.33M	Hold	71,310	–	–	0.01%	544
2020 Q4	$1.2M	Buy	+71,310	New	+$1.11M	0.01%	540
2017 Q1	–	Sell	-20,179	Closed	-$333K	–	576
2016 Q4	$333K	Sell	20,179 -980	-5%	-$15.4K	﹤0.01%	438
2016 Q3	$328K	Sell	21,159 -458,379	-96%	-$7.03M	﹤0.01%	426
2016 Q2	$6.81M	Buy	479,538 +232,638	+94%	+$3.45M	0.03%	269
2016 Q1	$3.66M	Buy	+246,900	New	+$3.4M	0.01%	327
2015 Q1	–	Sell	-28,000	Closed	-$437K	–	434
2014 Q4	$437K	Buy	+28,000	New	+$447K	﹤0.01%	400
2014 Q1	–	Sell	-26,900	Closed	-$478K	–	566
2013 Q4	$478K	Sell	26,900 -400	-1%	-$7.05K	﹤0.01%	550
2013 Q3	$472K	Sell	27,300 -8,200	-23%	-$144K	﹤0.01%	559
2013 Q2	$611K	Buy	+35,500	New	+$619K	﹤0.01%	513

Other funds holding ARCC

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $16.7B AUM 35.95% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CIM

CCLA Investment Management London, United Kingdom $6.23B AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ARCC Position: Q3 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Ares Capital (ARCC) in Q3 2021, closing a stake of 71,310 shares — an estimated $1.4M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ARCC in Q2 2013 and held it in 11 quarters. The position peaked at $6.81M in Q2 2016. 555 funds tracked by Wall St. Rank hold ARCC as of Q3 2021.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Ares Capital position as of Q3 2021 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 71,310 Ares Capital shares in Q3 2021, an estimated $1.4M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Ares Capital in Q2 2013 and held it in 11 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Ares Capital position peaked at $6.81M in Q2 2016.
555 funds tracked by Wall St. Rank held Ares Capital as of Q3 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2021, filed 12 Nov 2021.